The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets

KRKA, d.d., Novo mestoPA1347/044/001

Main Information

Trade NameAmoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets
Active SubstancesAmoxicillin
Clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1))
Dosage FormFilm-coated tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/044/001

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor


License statusAuthorised
Licence Issued18/09/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0037-073-003
Interchangeable List DocumentPDF of Interchangeable List
« Back